SCHEMBL30006609

SCHEMBL30006609

Cc1nnc2n1-c1c(c3c(c(-c4cccc5c4ccn5CC(F)F)c1C(F)(F)F)OCC3)NC2(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23658841 1.00 — —
SCHEMBL23647886 0.91 — —
SCHEMBL30006033 0.91 — —
SCHEMBL23658620 0.90 — —
SCHEMBL30006206 0.90 — —
SCHEMBL24767211 0.79 — —
SCHEMBL30006118 0.79 — —
SCHEMBL30005998 0.78 — —
SCHEMBL23658842 0.78 — —
SCHEMBL21636604 0.78 HTR2C (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4090660-A1 QUINOXALINE DERIVATIVES Grünenthal GmbH (DE) 2022-11-23 — — EP claimed
EP-4090660-A1 QUINOXALINE DERIVATIVES Grünenthal GmbH (DE) 2022-11-23 — — EP disclosed
Send feedback